Ubs Group Ag Athersys, Inc Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
BUY
$0.18 - $0.86 $30,196 - $144,270
167,756 Added 30.12%
724,652 $188,000
Q1 2022

May 16, 2022
SELL
$0.6 - $1.06 $52,804 - $93,288
-88,008 Reduced 13.65%
556,896 $338,000
Q4 2021

Feb 14, 2022
BUY
$0.85 - $1.4 $149,058 - $245,508
175,363 Added 37.35%
644,904 $581,000
Q3 2021

Nov 15, 2021
SELL
$1.33 - $1.77 $34,997 - $46,575
-26,314 Reduced 5.31%
469,541 $625,000
Q2 2021

Aug 13, 2021
SELL
$1.41 - $1.94 $306,941 - $422,316
-217,689 Reduced 30.51%
495,855 $714,000
Q1 2021

May 12, 2021
BUY
$1.61 - $2.77 $1.11 Million - $1.92 Million
692,145 Added 3234.47%
713,544 $1.28 Million
Q4 2020

Feb 11, 2021
BUY
$1.55 - $2.24 $7,576 - $10,949
4,888 Added 29.6%
21,399 $37,000
Q3 2020

Nov 12, 2020
BUY
$1.91 - $3.08 $18,251 - $29,432
9,556 Added 137.4%
16,511 $32,000
Q2 2020

Jul 31, 2020
SELL
$1.97 - $3.98 $340,727 - $688,372
-172,958 Reduced 96.13%
6,955 $19,000
Q1 2020

May 01, 2020
SELL
$1.17 - $3.0 $94,830 - $243,156
-81,052 Reduced 31.06%
179,913 $539,000
Q4 2019

Feb 14, 2020
BUY
$1.16 - $1.42 $76,106 - $93,164
65,609 Added 33.58%
260,965 $321,000
Q3 2019

Nov 14, 2019
BUY
$1.21 - $1.65 $231,393 - $315,536
191,234 Added 4639.35%
195,356 $259,000
Q2 2019

Aug 14, 2019
BUY
$1.39 - $2.03 $2,780 - $4,059
2,000 Added 94.25%
4,122 $7,000
Q1 2019

May 14, 2019
SELL
$1.39 - $1.71 $12,779 - $15,721
-9,194 Reduced 81.25%
2,122 $3,000
Q4 2018

Feb 14, 2019
BUY
$1.41 - $2.16 $8,966 - $13,735
6,359 Added 128.28%
11,316 $17,000
Q3 2018

Nov 14, 2018
SELL
$1.86 - $2.18 $2,012 - $2,358
-1,082 Reduced 17.92%
4,957 $11,000
Q2 2018

Aug 14, 2018
SELL
$1.76 - $2.79 $17,515 - $27,766
-9,952 Reduced 62.24%
6,039 $12,000
Q1 2018

May 15, 2018
BUY
$1.34 - $2.03 $17,914 - $27,139
13,369 Added 509.88%
15,991 $29,000
Q4 2017

Feb 14, 2018
SELL
$1.65 - $2.45 $6,413 - $9,523
-3,887 Reduced 59.72%
2,622 $5,000
Q3 2017

Nov 14, 2017
SELL
$1.5 - $2.55 $15,289 - $25,992
-10,193 Reduced 61.03%
6,509 $13,000
Q2 2017

Aug 14, 2017
BUY
N/A
13,351 Added 398.42%
16,702 $25,000
Q1 2017

Nov 14, 2017
BUY
N/A
3,351
3,351 $6,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email